Concurrent Chemoradiotherapy Articles

Articles

Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy.

To evaluate clinical outcomes of three-dimensional conformal radiotherapy (3D-CRT) alone in patients with bladder cancer who were unfit for concurrent standard chemotherapy.
Between January 2007 and May 2016, 34 patients (20 men, 14 women) aged 65-97 years (median=83) with bladder cancer cT1-4bN0-1M1 were treated with conformal whole-bladder radiotherapy with fractions of 1.
Published November 11, 2016
Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer.

PURPOSE - To evaluate survival rates and prognostic factors related to treatment outcomes after bladder preserving therapy including transurethral resection of bladder tumor, radiotherapy (RT) with or without concurrent chemotherapy in bladder cancer with a curative intent.

Published January 14, 2016
SIU 2017: Use of Concurrent Chemotherapy with Radiation Therapy for Bladder Cancer in the United States: A Quality of Care Comparative Effectiveness Study
Lisbon, Portugal (UroToday.com) For older bladder cancer patients, there is limited evidence of the efficacy of concurrent chemotherapy with radiation therapy in the community setting. The authors attempted to assess the relationship between concurrent chemotherapy use and survival in a large, population-based cohort of older patients with muscle-invasive bladder cancer.
Published October 25, 2017